Category: Medical
AstraZeneca’s AZD7798: A Promising New Chapter in Crohn’s Care
AstraZeneca’s AZD7798 represents a precision-targeted approach to Crohn’s treatment that could reduce side effects while improving effectiveness. This Phase II trial offers hope for a fundamentally different way of managing IBD inflammation.
Bariatric Surgery May Reduce IBD Complications by One-Third
New Swedish research reveals that bariatric surgery may reduce serious IBD complications by one-third, challenging previous concerns about surgery risks for people with both IBD and obesity. This groundbreaking study suggests that addressing obesity through surgery might actually improve overall IBD management and quality of life.
IBD and Brain Health: What New Dementia Research Means for You
New research reveals a concerning connection between IBD and brain health, showing that chronic gut inflammation may increase dementia risk and accelerate cognitive decline. Here’s what this means for our community and how to protect both your gut and brain health.
New Research Links Red Meat to IBD Risk – What It Means for You
New research reveals how red meat consumption may disrupt gut bacteria and increase inflammation, potentially affecting IBD risk and symptoms. Here’s what this means for our community and how to think about your protein choices.
Navigating Fertility Dreams with Crohn’s: What You Need to Know
New research provides important insights for people with Crohn’s disease considering starting a family, especially those who have had certain surgeries. While challenges exist, understanding the facts can help you make informed decisions about your fertility journey.
The Critical Importance of Early IBD Detection and Action
Healthcare experts emphasize how early detection and comprehensive team-based care can transform the IBD journey. Learn why recognizing symptoms early and seeking prompt treatment makes all the difference in long-term outcomes.
Teen Pilot with Crohn’s Shows Us What’s Possible When We Refuse Limits
A 15-year-old pilot with Crohn’s disease is challenging everything we think we know about living with IBD. His story proves that with the right approach, our diagnoses don’t have to limit our dreams—they just change how we pursue them.
When Standard IBD Meds Aren’t Enough: The Promise of Dose Adjustments
New research suggests that adjusting biologic medication doses could provide better outcomes for IBD patients. This personalized approach offers hope for those experiencing partial relief with standard dosing protocols.
New Stem Cell Trial Offers Real Hope for Crohn’s Patients
Hope Biosciences Research Foundation has launched a Phase II clinical trial exploring stem cell therapy for Crohn’s disease. This innovative approach targets inflammation at its source rather than just managing symptoms, offering new hope for patients who’ve exhausted traditional treatments.
Beyond Stomach Pain: Crohn’s Hidden Complications We Need to Discuss
A rare Crohn’s complication case reminds us why staying informed and working closely with specialized healthcare teams matters. While extremely uncommon, understanding the full spectrum of IBD helps us be better advocates for our health.
